publication . Article . 2016

Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine.

Pol Andrés Benito;
Open Access
  • Published: 15 Mar 2016 Journal: Journal of Alzheimer's Disease, volume 51, pages 489-500 (issn: 1387-2877, eissn: 1875-8908, Copyright policy)
  • Publisher: IOS Press
  • Country: Spain
Abstract
The authors’ work is supported by CIBERNED (Institute of Health Carlos III, Spanish Ministry of Economy and Competitiveness)
Subjects
Medical Subject Headings: lipids (amino acids, peptides, and proteins)mental disorders
free text keywords: Alzheimer, Malaltia d', Cannabinoides -- Receptors, Cannabis, Malaltia d'Alzheimer, Amiloïdosi, Metabolisme, Farmacologia, Agents noòtrops, Alzheimer's disease, Amyloidosis, Metabolism, Nootropic agents, Clinical Psychology, Geriatrics and Gerontology, Psychiatry and Mental health, General Medicine, Pharmacology, Genetically modified mouse, Transgenic Model, Cannabinoid receptor type 2, Knockout mouse, Endocrinology, medicine.medical_specialty, medicine, Hyperphosphorylation, Internal medicine, Disease, Cannabidiol, medicine.drug, business.industry, business, Amyloid, Neuroscience
Powered by OpenAIRE Open Research Graph
Any information missing or wrong?Report an Issue
publication . Article . 2016

Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine.

Pol Andrés Benito;